Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-019042
Filing Date
2026-02-23
Accepted
2026-02-23 09:00:28
Documents
3
Period of Report
2026-02-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0277961-6k_ascentage.htm 6-K 11839
2 PRESS RELEASE DATED FEBRUARY 23, 2026 ea027796101ex99-1_ascentage.htm EX-99.1 13895
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9210
  Complete submission text file 0001213900-26-019042.txt   39730
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 26662255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)